CVX
38
6
CHRW
67
3
RCL
88
-2
WDC
38
-3
RSG
77
4
AMAT
43
-5
STZ
58
3
KHC
17
4
HPE
70
2
VLO
42
2
GOOG
69
-10
BLK
70
-2
BMY
61
-3
KEY
46
-2
WFC
80
-2
SRE
66
-3
CI
52
-7
DVA
72
-3
AIZ
78
2
VNO
60
8
CVX
38
6
CHRW
67
3
RCL
88
-2
WDC
38
-3
RSG
77
4
AMAT
43
-5
STZ
58
3
KHC
17
4
HPE
70
2
VLO
42
2
GOOG
69
-10
BLK
70
-2
BMY
61
-3
KEY
46
-2
WFC
80
-2
SRE
66
-3
CI
52
-7
DVA
72
-3
AIZ
78
2
VNO
60
8
Financhill
Back

Skye Bioscience 10K Form

Sell
42

SKYE
Skye Bioscience

Last Price:
5.57
Seasonality Move:
51.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SKYE News And Ratings

See the #1 stock for the next 7 days that we like better than SKYE

SKYE Financial Statistics

Sales & Book Value

Annual Sales: $339.93K
Cash Flow: $-7.13M
Price / Cash Flow: 0
Annual Sales: $2.59
Price / Book: 2.25

Profitability

EPS (TTM): -3.90790
Net Income (TTM): $-42.29M
Gross Margin: $208.59K
Return on Equity: 0%
Return on Assets: 0%

Skye Bioscience Earnings Forecast

Key Skye Bioscience Financial Ratios

  • The Gross Profit Margin over the past 2 years for SKYE is 61.36%.
  • The Selling, General & Administrative Expenses for SKYE have been equal to 43.69% of Gross Profit Margin.
  • The Interest Expense is -2.41% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Skye Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SKYE
Website: skyebioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SKYE Technical Analysis vs Fundamental Analysis

Sell
42
Skye Bioscience (SKYE) is a Sell

Is Skye Bioscience a Buy or a Sell?

  • Skye Bioscience stock is rated a Sell
    The current Skye Bioscience [SKYE] share price is $5.32. The Score for SKYE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.